New heart pump takes on ECMO in High-Stakes stenting trial
NCT ID NCT06373120
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new temporary heart pump called CorVad against the standard ECMO machine in 262 high-risk patients who need complex heart stenting. The goal is to see which device better keeps the heart stable during the procedure and reduces complications like death, stroke, or kidney injury. Participants have severe coronary artery disease and weak hearts, making them too risky for bypass surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CorVad microaxial flow pump (a temporary heart assist device)
What this could lead to
If it works, this could show that a smaller, less invasive heart pump is safer and more effective than ECMO for supporting high-risk patients during complex stenting procedures.
What could go wrong
This is a relatively early randomized trial (262 patients) comparing two devices, so results may not apply to all patients. Both devices carry risks like bleeding, stroke, or kidney injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLEX CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ling Tao
Xi'an, Shannxi, 710032, China